Literature DB >> 8648923

Risk of developing end-stage renal disease in a cohort of mass screening.

K Iseki1, C Iseki, Y Ikemiya, K Fukiyama.   

Abstract

The prognostic significance of abnormal findings has not been demonstrated in a setting of mass screening. To evaluate the relative risk of end-stage renal disease (ESRD) indicated by various results of community-based mass screening, we utilized the registries of both community mass screening and chronic dialysis programs. In 1983, a total of 107,192 subjects over 18 years of age (51,122 men and 56,070 women) participated in dipstick urinalysis and blood pressure measurement in Okinawa, Japan. During ten years of follow-up, we identified 193 dialysis patients (105 men and 88 women) among them. Logistic regression analysis of clinical predictors of ESRD over 10 years was done and the adjusted odds ratio and 95% confidence interval were calculated in each of the predictors with adjustment to others. In the clinical predictors such as sex, age at screening, proteinuria, hematuria, systolic and diastolic blood pressure, proteinuria was the most potent predictor of ESRD (adjusted odds ratio 14.9, 95% confidence interval 10.9 to 20.2), and the next most potent predictor was hematuria (adjusted odds ratio 2.30, 95% confidence interval 1.62 to 3.28). Being of male gender was a significant risk factor for ESRD (adjusted odds ratio 1.41, 95% confidence interval 1.04 to 1.92). Diastolic blood pressure was also a significant predictor of ESRD (adjusted odds ratio 1.39, 95% confidence interval 1.17 to 1.64), but systolic blood pressure was not. In a mass screening setting, positive urine test, high diastolic blood pressure, and male sex were identified as the significant predictors of ESRD. Effect of glycosuria and other possible predictors of ESRD remained to be determined.

Entities:  

Mesh:

Year:  1996        PMID: 8648923     DOI: 10.1038/ki.1996.111

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  70 in total

Review 1.  Recent advances: nephrology.

Authors:  C R Tomson
Journal:  BMJ       Date:  2000-01-08

2.  Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Hideaki Yoshida; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-12-14       Impact factor: 2.801

Review 3.  The emerging role of the inflammasome in kidney diseases.

Authors:  Anthony Chang; Kichul Ko; Marcus R Clark
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

Review 4.  Classifying kidney problems: can we avoid framing risks as diseases?

Authors:  Catherine M Clase; Amit X Garg; Bryce A Kiberd
Journal:  BMJ       Date:  2004-10-16

5.  Chronic kidney disease: Proteinuria as a predictor of rapid eGFR decline.

Authors:  Kunitoshi Iseki
Journal:  Nat Rev Nephrol       Date:  2013-09-10       Impact factor: 28.314

6.  Glomerular isolated microscopic hematuria: urinary features and long term follow-up of a selected cohort of patients.

Authors:  Cecilia Bellincioni; Giuseppe Garigali; Giovanni B Fogazzi
Journal:  J Nephrol       Date:  2018-12-10       Impact factor: 3.902

7.  Cross-sex transplantation alters gene expression and enhances inflammatory response in the transplanted kidneys.

Authors:  Lei Wang; Jiangping Song; Shaohui Wang; Jacentha Buggs; Rongjun Chen; Jie Zhang; Liqing Wang; Song Rong; Wenbin Li; Jin Wei; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

8.  Diagnostic accuracy of urine dipsticks for detecting albuminuria in indigenous and non-indigenous children in a community setting.

Authors:  Leigh Haysom; Rita Williams; Elisabeth Hodson; Pamela Lopez-Vargas; L Paul Roy; David Lyle; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2008-09-25       Impact factor: 3.714

9.  Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa.

Authors:  Kunitoshi Iseki; Masaru Horio; Enyu Imai; Seiichi Matsuo; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2008-10-15       Impact factor: 2.801

10.  Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.

Authors:  Taku Inoue; Kunitoshi Iseki; Chiho Iseki; Yusuke Ohya; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2009-05-15       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.